We subsequently investigated the specific oncogenic mechanism of ESCO2 after confirming that ESCO2 knockdown prevents HCC cell growth by inducing G1-S phase cell cycle arrest and apoptosis. This evidence concerns the gene ESCO2 and hepatocellular carcinoma.